Nitroimidazole bioreductive metabolism
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (6) , 887-896
- https://doi.org/10.1016/0006-2952(87)90181-x
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- DNA damage in normal and neoplastic mouse tissues after treatment with misonidazole in vivoBiochemical Pharmacology, 1985
- Studies on the mechanisms of thalliummediated inhibition of hepatic mixed function oxidase activityBiochemical Pharmacology, 1984
- 2-hydroxylaminoimidazoles—unstable intermediates in the reduction of 2-nitroimidazolesBiochemical Pharmacology, 1984
- Nitroimidazoles as anaerobic electron acceptors for xanthine oxidaseBiochemical Pharmacology, 1982
- Activation of misonidazole by rat liver microsomes and purified NADPH-cytochrome c reductaseBiochemical Pharmacology, 1982
- Reduction of misonidazole and its derivatives by xanthine oxidaseBiochemical Pharmacology, 1981
- Role of the intestinal flora in the metabolism of misonidazoleBiochemical Pharmacology, 1980
- Metabolic activation of nitrofurantoin—possible implications for carcinogenesisBiochemical Pharmacology, 1979
- The role of catalytic superoxide formation in the O2 inhibition of nitroreductaseBiochemical and Biophysical Research Communications, 1975
- Stability of suspensions of rat liver microsomes quick-frozen with liquid nitrogen and stored at -85°Biochemical Pharmacology, 1974